This investigation identified the ImmuView® S. pneumoniae and L. pneumophila Urinary Antigen Test as the most sensitive point-of care test for patients presenting with pneumonia.
The combined testing ImmuView® also has the benefit of providing both results in one assay, making it easier to perform and cheaper to identify the correct infectious agent.
This combined testing also fits very well with the national recommendation in different countries for simultaneous testing for these two agents.